A vector expressing feline mature IL-18 fused to IL-1β antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus

Vaccine

Volumn 23, Issue 29, 2005, Pages 3814-3823

  O'Donovan, Lucy H ^a   McMonagle, Elizabeth L ^a   Taylor, Samantha ^a   Bain, Derek ^a,b   Pacitti, Angela M ^a   Golder, Mathew C ^a   McDonald, Michael ^a   Hanlon, Linda ^a   Onions, David E ^a   Argyle, David J ^a,c   Jarrett, Oswald ^a   Nicolson, Lesley ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cytokine; FeLV; Vaccine

Indexed keywords

DNA VACCINE; FELINE LEUKEMIA VIRUS VACCINE; INTERLEUKIN 12; INTERLEUKIN 18;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EXPRESSION VECTOR; FELINE LEUKEMIA VIRUS; GENE CONSTRUCT; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; VIREMIA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; BONE MARROW; CAT DISEASES; CATS; GENETIC VECTORS; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-18; LEUKEMIA VIRUS, FELINE; PROTEIN SORTING SIGNALS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE INFECTIONS; RETROVIRIDAE PROTEINS, ONCOGENIC; TUMOR VIRUS INFECTIONS; VACCINES, DNA; VIRAL VACCINES;

EID: 21044459009     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.026     Document Type: Article

References (58)

1. L. Hanlon, D. Argyle, D. Bain, L. Nicolson, S. Dunham, and M.C. Golder Feline leukaemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors J Virol 75 2001 8424 8433
2. E.A. Hoover, R.G. Olsen, L.E. Mathes, and J.P. Schaller Relationship between feline leukaemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats Cancer Res 37 1977 3707 3710
3. W.D. Hardy Jr., P.W. Hess, E.G. MacEwen, A.J. McClelland, E.E. Zuckerman, and M. Essex Biology of feline leukaemia virus in the natural environment Cancer Res 36 1976 582 588
4. J.N. Flynn, L. Hanlon, and O. Jarrett Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes Immunology 101 2000 120 125
5. O. Jarrett Strategies of retrovirus survival in the cat Vet Microbiol 69 1999 99 107
6. J.N. Flynn, S.P. Dunham, V. Watson, and O. Jarrett Longitudinal analysis of feline leukaemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection J Virol 76 2002 2306 2315
7. J.E. Post, and L. Warren Feline leukaemia virus vol. 151 1980 Elsevier North Holland New York
8. J.L. Rojko, E.A. Hoover, S.L. Quackenbush, and R.G. Olsen Reactivation of latent feline leukaemia virus infection Nature 298 1982 385 388
9. N.C. Pedersen, S.M. Meric, E. Ho, L. Johnson, S. Plucker, and G.H. Theilen The clinical significance of latent feline leukaemia infection in cats Feline Pract 14 1984 32 48
10. A.M. Pacitti, and O. Jarrett Duration of the latent state in feline leukaemia virus infections Vet Rec 117 1985 472 474
11. R.W. Sebring, H.-J. Chu, L.G. Chavez, D.S. Sandblom, D.R. Hustead, and B. Dale Feline leukaemia virus vaccine development JAVMA 10 1991 1413 1419
12. D.L. Hines, J.A. Cutting, D.L. Dietrich, and J.A. Walsh Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukaemia virus infection JAVMA 10 1991 1428 1430
13. S.M. York, and C.J. York Development of a whole killed feline leukaemia virus vaccine JAVMA 10 1991 1419 1422
14. M.G. Lewis, L.E. Mathes, and R.G. Olsen Protection against feline leukaemia by vaccination with a subunit vaccine Infect Immun 34 1991 888 894
15. C.R. Kensil, C. Barrett, N. Kushner, G. Beltz, J. Storey, and U. Patel Development of a genetically engineered vaccine against feline leukaemia virus infection JAVMA 199 1991 1423 1427
16. D.J. Marciani, C.R. Kensil, G.A. Beltz, C.-H. Hung, J. Cronier, and A. Aubert Genetically-engineered subunit feline leukaemia virus: protective immune response in cats Vaccine 9 1991 89 96
17. J. Tartaglia, O. Jarrett, J.C. Neil, P. Desmettre, and E. Paoletti Protection of cats against feline leukaemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL J Virol 67 1991 2370 2375
18. A.H. Sparkes Feline leukaemia virus: a review of immunity and vaccination J Small Anim Pract 38 1997 187 194
19. M.A. Stewart, M. Warnock, A. Wheeler, N. Wilkie, J.I. Mullins, and D.E. Onions Nucleotide sequences of a feline leukaemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses J Virol 58 1986 825 834
20. M.J. Micallef, T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, and M. Namba Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production Eur J Immunol 26 1996 1647 1651
21. T.T. Zhang, W. Kawaka, M.H. Qureshi, H. Okamura, M. Kurimoto, and A. Sato Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal ÿxudates cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells Infect Immun 65 1997 3594 3599
22. V.E.C.J. Schijns, C.M.H. Wierda, T.W. Vahlenkamp, and M.C. Horzinek Molecular cloning of cat interleukin-12 Immunogenetics 45 1997 462 463
23. Hanlon L. Feline IL-12 and IL-18: adjuvants in FeLV DNA vaccination studies. Ph.D. thesis. Glasgow. United Kingdom: University of Glasgow; 1999.
24. S. Gillessen, D. Carvajal, P. Ling, F.J. Podlaski, D.L. Stremlo, and P.C. Familletti Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist Eur J Immunol 25 1995 200 206
25. P. Ling, M.K. Gately, U. Gubler, A.S. Stern, P. Lin, and K. Hollfelder Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity J Immunol 154 1995 116 127
26. R. Anderson, I. Macdonald, T. Corbett, G. Hacking, M.W. Lowdell, and H.G. Prentice Construction and biological characterisation of an interleukin-12 fusion protein (flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus Hum Gene Ther 8 1997 1125 1135
27. G.J. Lieschke, P.K. Rao, M.K. Gately, and R.C. Mulligan Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo Nat Biotechnol 15 1997 35 40
28. H. Okamura, H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, and T. Tanimoto Cloning of a new cytokine that induces IFN-gamma production by T cells Nature 378 1995 88 91
29. Y. Gu, K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, and M.A. Fleming Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme Science 275 1997 206 209
30. G.A. Wingren, O. Bjorkdahl, T. Labuda, L. Bjork, U. Andersson, and U. Gullberg Fusion of a signal sequence to the interleukin-1β gene directs the protein from cytoplasmic accumulation to extracellular release Cell Immunol 169 1996 226 237
31. L.H. O'Donovan, E.L. McMonagle, S. Taylor, D.J. Argyle, and L. Nicolson Bioactivity and secretion of interleukin-18 (IL-18) generated by equine and feline IL-18 expression constructs Vet Immun Immunopathol 102 2004 421 428
32. O. Jarrett, and J.-P. Ganière Comparative studies of the efficacy of a recombinant feline leukaemia virus vaccine Vet Rec 138 1996 7 11
33. R.B. DuBridge, P. Tang, H.C. Hsia, P.M. Leong, J.H. Miller, and M.P. Calos Analysis of mutation in human cells by using Epstein-Barr virus shuttle system Mol Cell Biol 7 1987 379 387
34. S. Marazzi, S. Blum, R. Hartmann, D. Gundersen, M. Schreyer, and S. Argraves Characterisation of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes J Immunol 161 1998 138 147
35. E.L.J. McMonagle, S. Taylor, H. van Zuilekom, L. Sanders, N. Scholtes, and L.J. Keanie Production of biologically active equine interleukin 12 through expression of p35, p40 and single chain IL-12 in mammalian and baculovirus expression systems Equine Vet J 33 2001 693 698
36. O. Jarrett, H.L. Laird, and D. Hay Determinants of the host range of feline leukaemia viruses J Gen Virol 20 1973 169 175
37. D.A. Harbour, D.A. Gunn-Moore, T.J. Gruffydd-Jones, S.M.A. Caney, J. Bradshaw, and O. Jarrett Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least twelve months following a primary course of immunisation with Leukocell 2 vaccine Vaccine 20 2002 2866 2872
38. B.R. Madewell, and O. Jarrett Recovery of feline leukaemia virus from non-viraemic cats Vet Rec 112 1983 339 342
39. M.J. Hosie, and O. Jarrett Serological responses of cats to feline immunodeficiency virus AIDS 4 1990 215 220
40. M.J. Hosie, J.N. Flynn, M.A. Rigby, C. Cannon, T. Dunsford, and N.A. Mackay DNA vaccination affords significant protection against Feline immunodeficiency virus infection without inducing detectable antibodies J Virol 72 1998 7310 7319
41. E. De Maeyer, and J. De Maeyer-Gulgnard Interferon-gamma Curr Opin Immunol 4 1992 321 336
42. T. Tsuji, K. Hamajima, J. Fukushima, K.-Q. Xin, N. Ishii, and I. Aoki Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12 J Immunol 158 1997 4008 4013
43. K. Yamakami, S. Akao, M. Sato, Y. Nitta, J.-I. Miyazaki, and T. Tadakuma A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection Parasitol Int 50 2001 81 91
44. L. Zitvogel, H. Tahara, Q. Cai, W.J. Storkus, G. Muller, and S.F. Wolf Construction and characterisation of retroviral vectors expressing biologically active human interleukin-12 Hum Gene Ther 5 1994 1493 1506
45. T. Kokuho, S. Watanabe, Y. Yokomizo, and S. Inumaru Production of biologically active, heterodimeric porcine interleukin-12 using a monocistronic baculoviral expression system Vet Immunol Immunopathol 72 1999 289 302
46. O'Donovan LH. Feline IL-12 and IL-18 as adjuvants to a DNA vaccine for FeLV. Ph.D. thesis. Glasgow, United Kingdom: University of Glasgow; 2002.
47. S.P. Dunham, J.N. Flynn, M.A. Rigby, J. McDonald, J. Bruce, and C. Cannon Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18 Vaccine 20 2002 1483 1496
48. H.L. Glansbeek, B.L. Haagmans, E.G. te Lintelo, H.F. Egberink, V. Duquesne, and A. Aubert Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus J Gen Virol 83 2002 1 10
49. H.-W. Che, C.-H. Pan, H.-W. Huan, M.Y. Liau, J.-R. Chiang, and M.-H. Tao Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by coadministration of an IL-12-expressing plasmid J Immunol 166 2001 7419 7426
50. J.S. Orange, S.F. Wolf, and C.A. Biron Effects of IL-12 on the response and susceptibility to experimental viral infections J Immunol 152 1994 1253 1264
51. J.J. Lasarte, F.J. Corrales, N. Casares, A.L.-D. de Cerio, C. Qian, and X. Xie Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide J Immunol 162 1999 5270 5277
52. O. Billaut-Mulot, T. Idziorek, E. Ban, L. Kremer, L. Dupré, and M. Loyens Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/boost vaccine Vaccine 19 2001 95 102
53. L. Dupré, L. Kremer, I. Wolowczuk, G. Riveau, A. Capron, and C. Locht Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection Vaccine 19 2001 1373 1380
54. T. Dao, K. Ohashi, T. Kayano, M. Kurimoto, and H. Okamura Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells Cell Immunol 173 1996 230 235
55. T. Dao, W.Z. Mehal, and I.N. Crispe IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells J Immunol 161 1998 2217 2222
56. N. Clark, N.N. Kushner, C.B. Barrett, C.R. Kensil, D. Salsbury, and S. Cotter Efficacy and safety field trials of a recombinant DNA vaccine against feline leukaemia virus infection JAVMA 199 1991 1433 1443
57. C.M. Leutenegger, F.S. Boretti, C.N. Mislin, J.N. Flynn, M. Schroff, and A. Habel Immunisation of cats against Feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif J Virol 74 2000 10447 10457
58. A.M. Cuisinier, V. Mallet, A. Meyer, C. Caldora, and A. Aubert DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus Vaccine 15 1997 1085 1094